Kestra Medical Technologies (KMTS) Profit After Tax (2024 - 2026)

Kestra Medical Technologies (KMTS) has reported Profit After Tax for 3 consecutive years, with -$38.8 million the latest figure, recorded in Q2 2026.

• In Q2 2026, Profit After Tax rose 25.39% year-over-year to -$38.8 million; the TTM figure through Apr 2026 stood at -$131.6 million (down 15.38% YoY), while the FY2026 annual figure was -$131.6 million, down 15.64% from the prior year.
• Profit After Tax eased to -$38.8 million in Q2 2026 per KMTS's latest filing, from -$34.2 million in the prior quarter.
• Across five years, Profit After Tax topped out at -$19.9 million in Q3 2024 and bottomed at -$52.1 million in Q2 2025.
• Historically, Profit After Tax has averaged -$29.0 million across 3 years, with a median of -$24.1 million in 2024.
• Annual changes were most pronounced in 2025 — Profit After Tax plunged 133.59% — and 2026, when it advanced 25.39%.
• Kestra Medical Technologies' Profit After Tax stood at -$20.4 million in 2024, then slumped by 60.96% to -$32.8 million in 2025, then decreased by 18.45% to -$38.8 million in 2026.
• Business Quant data shows KMTS's Profit After Tax at -$38.8 million in Q2 2026, -$34.2 million in Q1 2026, and -$32.8 million in Q4 2025.